Not Tagged
Not Tagged
['gyn', 'ovarian']
gyn posters #asco22 o'malley ab 5552 p431 real-world use, tolerability, and dose modifications of parp inhibitors in ovarian cancer.
retro study - differences between parpis in persistence w/ therapy &amp; risk of experiencing a clinical events
#gyncsm 
#ovca survivor; research advocate; author; co-moderator #gyncsm chat;  #ASCO22 Feature Voice  COI: https://t.co/AUF1EprNVt Opinions are my own.